The clinical information you need, at your fingertips.

Medical News for You

Cell

Younger adults with colorectal, breast cancer show distinct gut bacteria

The gut microbes patients carried before treatment tracked with how long they survived and who developed diarrhea during chemotherapy. . .

Drug pipeline

Tulisokibart delivers first positive anti-TL1A phase 2 results in hidradenitis suppurativa

Investigational therapy showed improvements in disease activity and quality of life in a condition with persistent unmet treatment needs. . .

J Clin Oncol

Fills of oral blood cancer drugs fall as out-of-pocket costs rise

Approved prescriptions went unfilled far more often when patients faced the highest out-of-pocket costs, and most first submissions to insurers were rejected. . .

Company news

Recarbrio discontinued from US market

Merck says the withdrawal is unrelated to safety or effectiveness concerns; alternative treatments for multidrug-resistant Gram-negative infections remain available. . .

EADV 2026

10h

Are GLP-1 drugs affecting patients’ nails?

Nail detachment and discoloration were markedly more common among GLP-1 receptor agonist users than matched controls. . .

Lancet Reg Health Am

13h

EASD 2026: Half of young adults with T2D achieved remission with diet-plus-exercise program

Intensive calorie restriction paired with structured exercise produced high remission rates while preserving muscle mass. . .

EASD 2026

Eloralintide boosts tirzepatide weight loss to 23% in T2D

Adding a selective amylin receptor agonist to the highest incretin dose led to greater weight loss and larger A1C reductions versus incretin alone. . .

Lancet Obstet Gynaecol

EASD 2026: No birth-defect signal with GLP-1s in early pregnancy, but gaps remain

Most evidence addresses early exposure; safety later in pregnancy and during breastfeeding is unclear. . .

Lancet Oncol

One in eight cancers linked to infections worldwide

New global analysis suggests millions of cancer cases could be prevented through wider use of vaccines, screening, and treatment. . .